In rats post-myocardial infarction (MI), sympathetic hyperactivity can be prevented by blockade of brain mineralocorticoids receptors (MR). Stimulatory responses to central infusion of aldosterone can be blocked by benzamil, and therefore appear to be mediated via Na + channels, presumably ENaC, in the brain. To evaluate this concept for endogenous mineralocorticoids in Wistar rats post-MI, effects of blockade of MR and of Na + channels in the brain were examined. At 3 days after coronary artery ligation, intracerebroventricular (icv) infusions were started with spironolactone (400 ng/kg/h) or its vehicle, or benzamil (4 µg/kg/h) or its vehicle using osmotic minipumps. Rats with sham ligation served as control. After 4 weeks, in conscious rats, MAP, HR, renal sympathetic nerve activity (RSNA) were recorded at rest and in response to air-jet stress, icv injection of 2-adrenoceptor agonist guanabenz, and iv infusion of phenyleprine and nitroprusside for baroreflex function. MI size was similar among the 4 groups of rats (~31%). In rats post-MI treated with vehicles, cardiac function was decreased (LVEDP up by 15 mmHg, LVPSP down by 32 mmHg, and LV dp/dt max down by 2000 mmHg/sec), sympathetic reactivity enhanced (~120% increase in magnitudes of excitatory RSNA responses to air stress and inhibitory RSNA responses to guanabenz), and baroreflex function impaired (~35% decrease in maximal slope of reflex). Blockade of brain Na + channels or brain MR similarly prevented sympathetic hyperactivity and impairment of baroreflex function, and improved cardiac function (LVEDP only up by 5 mmHg, LVPSP only down by 12 mmHg, and LV dp/dt max only down by 900 mmHg/sec). These findings suggest that in rats post-MI, increased binding of endogenous agonists to MR increases ENaC in the brain and thereby leads to sympathetic hyperactivity and progressive LV dysfunction.
Recent studies demonstrated that the central mechanisms leading to sympathetic hyperactivity in rats post-MI resemble the ones contributing to salt-sensitive hypertension in Dahl salt-sensitive (S) rats. In Dahl S rats on high salt intake, blockade of brain ouabain-like compounds (OLC), or of the brain renin-angiotensin system (RAS) prevents sympathetic hyperactivity and impairment of arterial baroreflex function, and prevents salt-induced hypertension (19) . Gomez-Sanchez et al demonstrated that blockade of brain aldosterone bio-synthesis with the 3 -hydroxysteroid dehydrogenase inhibitor, trilostane (17) , of brain mineralocorticoid receptors (MR) with spironolactone (15) , or of brain amiloride-sensitive Na + -channels with the amiloride analog benzamil (16), also prevents hypertension in Dahl S rats on high salt (15) . In rats, responses to intra-cerebroventricular (icv) infusion of aldosterone can be blocked by icv infusion of a MR antagonist (14) , benzamil or antibody Fab fragments binding brain OLC (39) . These findings suggest that in the brain increased binding of aldosterone to MR increases activity of amiloridesensitive Na + -channels, likely epithelial Na + -channels (ENaC), and thereby increases brain OLC and activity of the brain RAS (39) . We proposed that in Dahl S rats on high salt, increased binding of endogenous agonists to MR increases activity of ENaC in the brain, and thereby increases [Na + ] in the cerebro-spinal fluid (CSF) and brain interstitial space, the latter leading to increases in brain OLC and activity of brain RAS, sympathetic hyperactivity and hypertension (20, 40) .
Similar to Dahl S rats on high salt, in rats post-MI, blockade of brain OLC with Fab fragments (25) , or of the brain RAS (7, 38, 41) prevents sympathetic hyperactivity and impairment of arterial baroreflex function. In addition, blockade of brain OLC or the brain RAS markedly inhibits cardiac remodeling and cardiac dysfunction post-MI (25, 32, 38) . In rats post-MI, chronic blockade of brain MR with central infusion of spironolactone prevents the increased neuronal activity of the paraventricular nucleus (PVN) in the hypothalamus and decreases sympathetic drive (12, 42) . Recently we showed that in rats post-MI spironolactone administered either by icv infusion at the rate of 400ng/kg/h or orally at 80 mg/kg/day equally improves cardiac function and attenuates cardiac remodeling (24), suggesting that post-MI aldosterone appears to activate central pathways which influence peripheral mechanisms involved in cardiac remodeling. Whether post-MI these actions of aldosterone are related to increased ENaC in the brain has not yet been explored.
Hence the purpose of the present study was to examine whether chronic blockade of MR or of Na + channels, by chronic icv infusion of spironolactone or benzamil not only both prevent sympathetic hyperactivity, and impairment of arterial baroreflex function, but also both maintain better cardiac function in rats post-MI. If responses to increased binding of endogenous agonists to brain MR post-MI indeed involve an increase in ENaC activity in relevant brain areas, one may expect that chronic effects of central infusions of spironolactone and benzamil on sympathetic activation and LV dysfunction are largely the same.
Methods
Wistar rats (male, 200-250 g) were obtained from Charles River Breeding Laboratories, Montreal, Quebec, Canada. The rats were provided with a standard commercial rat chow and water ad libitum. The study was carried out in accordance with the guidelines of the Canadian Council on Animal Care, which conform to NIH guidelines and was approved by the University of Ottawa Animal Care and Use Committee.
After 5-7 days of acclimatization, acute left coronary artery ligation was performed to induce a MI as described previously (25, 41) . Briefly, under halothane inhalation, an intra-tracheal tube was inserted and connected with a respirator (Harvard Rodent Ventilator, model 683) with halothane and oxygen. The thorax was opened at the left fourth or fifth inter-costal space, and the left coronary artery was ligated 2-3 mm from its origin with a 6-0 suture. Positive end expiratory pressure was then applied to inflate the lung before the chest was closed in layers. Control (sham-operated) rats underwent the same surgical procedure without coronary artery ligation.
In surviving rats three days after the coronary artery ligation, under halothane anaesthesia, a L-shaped, 23 gauge stainless steel cannula was inserted into the right lateral cerebro-ventricle (19, 20) . Via PE 50-60 polyethylene tubing, the cannula was connected to an osmotic minipump (Alzet, Model 2004) for icv infusion for 4 weeks of one of the following treatments: 1. benzamil (4 µg/kg/h)(31); 2. vehicle for benzamil [aCSF with 15% propylene glycol (16)]; 3. spironolactone (400 ng/kg/h) (9); and 4. vehicle for spironolactone (aCSF with 0.2% alcohol). The pumps were located subcutaneously on the back of the rats. The infusion rate was 6µl/day. Icv infusion at this rate has only minor effects on central fluid homeostasis considering that the secretion rate of CSF in rats is about 150-350 µl /h (6) . During the same surgery, a 23 gauge stainless steel guide cannula was implanted 0.5 mm above the left lateral cerebro-ventricle and fixed with dental cement on the skull together with the L -shaped one (19) . Shamoperated rats underwent identical surgery without pump implantation and treatment.
Four weeks after mini-pump instrumentation, under halothane anaesthesia, the left femoral vein and artery were cannulated with PE 10 fused to PE 50 polyethylene tubing.
The left kidney was exposed via a left flank incision. One of the renal nerves was dissected free from surrounding tissue and hooked to a pair of silver electrodes. When an optimal signal of renal sympathetic nerve activity (RSNA) was observed, the electrodes and nerve were glued together with SilGel 604 (Wacker, Munich, Germany) and the electrodes were tunnelled to the back of the neck.
The experiment was started 4 hours after recovery from the anaesthesia. The intra-arterial catheter was connected to a transducer, and BP and HR were recorded through a polygraph (Model 7E, Grass Instrument Co., Quincy, Mass) and a Grass 7P44 tachograph. The electrodes were linked to a Grass P511 bandpass amplifier, and the amplified RSNA signals were channeled to a rectifying voltage integrator (Grass Model 7P10) and recorded through the polygraph. The RSNA signals (mV), together with BP and HR were also fed into an online computer equipped with a Grass data acquisition and analysis program (Polyview 2.0). The noise of RSNA was determined after the rats had been killed at the end, and subtracted from the total activity. Icv injections were done via a L-shaped stainless steel tubing (26 gauge) placed via the guide cannula so that its tip protruded 1.0 mm from the tip of the guide cannula into the left lateral cerebral ventricle. The outer side of the tubing was connected to a Hamilton micro-syringe via polyethylene tubing. After a 20 min stabilization, baseline MAP, HR and RSNA were recorded in resting animals for 5 min. Subsequently, the rat was blown twice onto the face with a jet of air (2 PSL, on pressure metre). Each lasted for 20 seconds with a 5 min interval. After a 20 min rest, phenylephrine (5-50 µg/min) was infused iv to obtain ramp increases of MAP by 50 mmHg over 1 min. Ten min after the responses had subsided, sodium nitroprusside (10-100 µg/min) was infused iv to obtain ramp decreases of MAP by 50 mmHg over 1 min. After another 20 min rest, the 2 adrenoceptor agonist guanabenz (30 and 60 µg in 3-6 µl) was injected icv over 30 seconds, with an interval of 20 min.
Rats were then anesthetized with halothane, and the right carotid artery isolated. With continuous monitoring of the arterial blood pressure via a PC equipped with software AcqKnowledge (ACQ 3.2), a 2 F high-fidelity micromanometer catheter (SPR-407, Millar Institute, Houston, Texas) was inserted into the carotid artery and passed retrogradely into the LV. Confirmation of the correct position was noted by the characteristic decrease in diastolic pressure that occurs with passage of the catheter across the aortic valves into the LV cavity. The waveforms of the pressure changes were recorded and analyzed to determine systolic blood pressure (SBP), diastolic blood pressure (DBP), HR, LV end-diastolic pressure (LVEDP), LV peak systolic pressure (LVPSP), and maximum rate of rise of LV pressure (dp/dt max ).
The rats were then sacrificed with 2 M KCl, and the heart was dissected and the infarct size measured as previously described (6) . Briefly, the LV tissue was pressed flat and the circumferences of the entire LV versus visualized infarct area were outlined on a transparent plastic sheet. The difference in weight between the two marked areas on the sheet was used to determine the infarct size.
Data analysis: Responses of MAP and HR were expressed as net changes from resting levels. The responses of RSNA were expressed as percent changes from resting levels. A nonlinear regression program (Sigmastat and Sigmaplot. Jandel Scientific) was used to analyse the baroreflex curve:
RSNA; a is the range of HR or RSNA; b is the slope coefficient; c is MAP at the midpoint range of RSNA or HR and d is the minimum of RSNA or HR. In each rat, raw data of MAP, HR and RSNA were fit to the logistic function to generate parameters a, b, c and d. The maximal slope of the baroreflex curve is defined as -ba/4. Data were expressed as mean ± SEM. One-way ANOVA was performed for comparison among groups. When F ratios were significant, Newman-Keuls test was applied to identify which groups were significantly different. Statistical significance was defined as p<.05.
Results
During the 4 weeks of follow-up, the survival rates of rats post-MI treated icv with spironolactone, benzamil, and either vehicle were similar (80-84%). There were no differences in the gain of body weight among the groups (Table 1) . Left ventricle infarct size was about 31% in all groups of rats post-MI. Hematocrit and plasma levels of Na + (Table 1) , and K + and Cl -(data not shown) did not differ among the groups.
Resting RSNA
Resting RSNA tended to be higher (p=0.20) in rats treated post-MI with vehicle compared with the sham-operated group. This tendency was not present in rats treated post-MI with icv spironolactone or benzamil (Table 1) .
Sympathetic Reactivity
In sham operated rats, air-jet stress caused peak increases in MAP by 8 mmHg, in RSNA by 13% of basal, and in HR by 10 bpm. Compared with the sham rats, the peak responses of MAP, RSNA and HR were increased by 100-120% in rats treated post-MI with icv infusion of either vehicle (Fig 1) . In contrast, in rats post-MI with icv infusion of spironolactone or benzamil the responses were similar to those in sham rats (Fig 1) .
In response to icv injection of guanabenz, MAP, RSNA and HR decreased simultaneously in a dose-related manner ( Table 2) . Compared with sham-operated rats, the peak inhibitory responses were increased by 120-150% in rats post-MI with icv infusion of either vehicle (Fig 1) . In rats post-MI with icv infusion of spironolactone or benzamil the extent of responses was significantly smaller, and similar to those in sham rats ( Table 2) .
Arterial Baroreflex Function
Intravenous nitroprusside and phenylephrine induced ramp decreases and increases in MAP and caused the expected ramp increases and decreases in RSNA ( Fig 2) and HR ( Fig 3) . Compared with the sham rats, in rats post-MI with icv infusion of either vehicle the reflex curves of RSNA or HR against MAP were not only shifted to the left but also became less steep, and the ranges of RSNA or HR and maximal slopes of RSNA or HR against MAP were significantly smaller, consistent with impaired baroreflex function. In rats post-MI with icv infusion of either spironolactone or benzamil maximal slopes of RSNA or HR against MAP were significantly steeper than in rats post-MI with icv vehicle, and not different from the sham rats. The ranges of RSNA also remained normal in rats post-MI with icv spironolactone or benzamil.
Cardiac function
In the two MI-groups treated with vehicle, resting systolic and diastolic BP were significantly lower versus sham-operated rats. The decrease in resting systolic but not diastolic BP was significantly attenuated in rats with icv infusion of either spironolactone or benzamil (Table 1) . Resting HR was similar in all groups (Table 1) .
Compared with the sham rats, in rats post-MI with icv infusion of either vehicle the LVPSP and LV dp/dt max were markedly lower, and LVEDP higher (Fig 4) . In rats post-MI with icv infusion of spironolactone or benzamil, the cardiac function was markedly improved as reflected in the higher LVPSP and LV dp/dt max , and lower LVEDP versus rats post-MI with icv vehicles. The LVPSP and LV dp/dt max remained significantly lower by about 12 mmHg and 900 mmHg/sec, and LVEDP significantly higher by about 5 mmHg in rats post-MI with icv spironolactone or benzamil versus the sham rats.
Discussion
In rats four weeks post-MI clear LV dysfunction was present, as reflected in decreases in LVPSP (~30 mmHg) and LV dp/dt max (~2000 mmHg/sec), and an increase in LVEDP (15 mmHg) . The decrease in cardiac function was associated with sympathetic hyperactivity and an impairment of arterial baroreflex function. The novel finding of the present study is that blockade of brain MR with icv spironolactone, and blockade of brain Na + channels with icv benzamil to the same extent prevent sympathetic hyperactivity and improve cardiac function post-MI.
Sympathetic Activity
In animal models of CHF post MI, Fra-like immunoreactivity (36) and the number of decreased activity in central inhibitory pathways (25, 41) , impaired baroreflex control of sympathetic nerve activity (12, 41) , and increased resting sympathetic tone (12, 24, 25) .
The primary mechanisms activating central pathways leading to sympathetic hyperactivity post-MI are still unclear. Post-MI, the circulating renin-angiotensin system (RAS) is activated with an increase in plasma renin activity and plasma Ang II (26, 33) .
Lindley et al suggested that increased plasma Ang II post-MI may activate AT 1 receptors in brain circumventricular organs such as the subfornical organ (SFO) or organum vasculosum of the lamina terminalis (OVLT), which signal to downstream nuclei such as PVN and SON activating sympatho-excitatory pathways (27) . Indeed CNS AT 1 receptor stimulation appears to play a crucial role. Icv infusion of losartan, at doses devoid of effects when infused peripherally, prevents sympathetic hyperactivity and improves baroreflex function in rats post-MI (7, 41) . Blockade of forebrain AT 1 receptors with losartan attenuates the increased neuronal activity of PVN, and decreases sympathetic nerve activity in rats with CHF post-MI. (12, 42 ). In addition, in rats post-MI blocking the brain RAS by icv infusion of the angiotensin-converting enzyme (ACE) inhibitor enalaprilat prevents sympathetic hyperactivity (10) , and injection of AT 1 receptor mRNA antisense into the PVN normalizes the enhanced cardiac sympathetic afferent reflex and decreases resting RSNA (44). Recently, we studied transgenic rats lacking specifically angiotensinogen in the brain, and showed that Ang II locally produced in the brain plays a major role in the CNS pathways leading to the sympathetic hyperactivity post-MI (38) .
These findings suggest that circulation derived Ang II may act on e.g. SFO or OVLT, but that in the central pathways locally produced Ang II acts as an essential neurotransmitter.
Effects of another component of the renin-angiotensin system aldosterone in the brain have recently received increasing attention. Treatment with the MR blocker spironolactone or eplerenone improves morbidity and mortality in patients with CHF post-MI, and it was generally assumed that these benefits resulted from blockade of the systemic effects of aldosterone on myocardial and vascular tissues (5). Francis et al (12) showed that in rats post-MI the integrated resting RSNA was increased (15.7±0.7 versus either icv or ip prevented the increase. In the present study, similar mean differences in resting RSNA as in the study by Francis et al (12) were observed but with more variation and therefore not statistically significant. Comparisons of absolute values of (multi-fiber)
RSNA recordings across groups of rats are usually considered to be of questionable validity (37) and should be interpreted with caution. The present study shows that icv spironolactone also prevents the enhanced responses of RSNA and HR to air-stress and icv guanabenz, consistent with prevention of increased activity in central sympathoexcitatory and decreased activity in sympatho-inhibitory pathways (30) post-MI. In addition, icv spironolactone prevents the impairment of the arterial baroreflex control of both RSNA and HR, consistent with the study by Francis et al (12) .
In peripheral tissues, the genomic effects following the binding of agonist to MR lead to an increase in ENaC expression and activity on the cell membrane (13) . Functional studies are suggestive for the same pattern in the brain, since sympatho-excitatory and pressor responses to icv infusion of aldosterone can be prevented by blockade of either MR or Na + channels in the brain (14, 39) . To our knowledge the present study is the first showing that in rat post-MI central responses to endogenous MR agonist also follow this pattern, since chronic icv infusion of benzamil and spironolactone equally prevent sympathetic hyperactivity and impairment of baroreflex function. Taking all together, we propose that in rat post-MI, among the primary events, increased binding of endogenous agonist to brain MR leads to increased expression of ENaC, and the latter is essential in the CNS pathways leading to sympatho-excitation. Aldosterone is present in CSF, and its concentration in the CSF correlates with that in plasma (22) . It has not yet been evaluated whether post-MI circulation derived or locally produced aldosterone or other MR agonists increase binding to MR in the brain. MRs as well as ENaC are present in the brain, including the choroid plexus and ventricular ependyma (31, 1) . Increased binding of agonist to MR and thereby increased ENaC at epithelial cells of the choroid plexus and ventricular ependyma may lead to an increase of [Na + ] in CSF and brain interstitium (2, 21) . The latter may act as a stimulus for production/release of OLC (18) by e.g. astrocytes (23) , leading to AT 1 receptor stimulation and sympathetic hyperactivity (25, 42) . We recently also identified MR and ENaC in nuclei such as the SON (1). Thus, activation of the aldosterone -MR-ENaC pathway may also directly increase Na + -entry into neurons or glia and thereby contribute to e.g. release of OLC.
Mineralocorticoids such as aldosterone may also affect Na + transport via non-genomic effects (43), which may not be mediated via MR binding and an increase in ENaC activity. Since both spironolactone and benzamil block all sympatho-excitatory responses post-MI, these effects may play only a minor role. Besides aldosterone, ENaC activity can also be increased by e.g. insulin (3) and vasopressin (28) . Whether insulin or vasopressin play a significant role in ENaC function in the brain has not yet been explored.
Cardiac Function
Assessment of LV function using a high-fidelity micromanometer catheter showed a significant increase in LVEDP, and decreases in LVPSP and LV dp/dt max as well as systolic BP in rats post-MI. Icv treatment with either spironolactone or benzamil significantly attenuated the increase in LVEDP and the decreases in LVPSP, LV dp/dt max and systolic BP, to levels which were modestly but still significantly different from control levels. Since the MI induced by coronary artery ligation leads to permanent tissue damage of the left ventricle, normal cardiac function cannot be expected. In rats post MI, blockade of brain MR by icv infusion of spironolactone also significantly attenuates cardiac remodeling (ie. prevents increases in internal circumferences and fibrosis in LV and RV) (24). Thus, both treatments increased systolic BP, but cardiac afterload or more specifically ventricular end-systolic wall stress may have remained the same or actually decreased as a result of a decrease in ventricular circumferences by the treatments. The tended to be increased in the present study, and in other studies (e.g. 10, 12, 24, 25) is generally found elevated. Post-MI, blockade of MR (7, 17) , ENaC (12, 24) , OLC (25), AT 1 receptors (41), or ACE (10) in the brain prevents sympathetic hyper-reactivity as well as prevents or reverses increased resting sympathetic tone (10, 12, 25,) , although in the present study the decrease in resting RSNA by the treatments is not significant. Post-MI sympathetic hyperactivity at rest, and particularly during stress, may maintain cardiac performance in the short-term, but in the long-term may contribute to progressive cardiac remodeling and thereby LV dysfunction. Besides increasing cardiac pre-and after-load via direct and indirect (e.g. renal) effects, sympathetic hyperactivity may exert adverse cardiac effects either directly or indirectly via increasing plasma and/or cardiac Ang II and aldosterone (24, 26, 34, 38) . CNS blockade may also impact on other factors which may contribute to progressive LV dysfunction. Tumor necrosis factor (TNF) -increases in plasma, heart and hypothalamus of rats post-MI (9) . TNF-may contribute to progressive cardiac remodeling and LV dysfunction (4) by e.g. increasing activity of the cardiac RAS (8) . Icv infusion of spironolactone prevents the progressive increase in plasma TNF-level (11) . Effects of central treatments on plasma vasopressin levels post-MI may also contribute to the extent of LV remodeling and dysfunction (29) .
Limitations of the study. When using regular electrodes, the RSNA signals usually deteriorate gradually over the post-operative time. RSNA, BP and HR were therefore recorded > 4 hr after the rats had recovered from the anesthesia. Persistent post-surgical stress may influence the responses to air stress and icv guanabenz, and possibly amplify the differences in responses to stress and guanabenz in rats post-MI compared to sham-operated rats, but unlikely can explain the normalization of sympathetic responses by the two treatments.
In summary, the present study demonstrates that in rats post-MI blockade of either brain MR with icv spironolactone, or brain Na + channels with icv benzamil to the same extent prevents sympathetic hyperactivity and improves cardiac function in rats post-MI. These findings suggest that in rats post-MI increased binding of endogenous agonists to MR and thereby increased ENaC in the brain leads to sympathetic hyperactivity and progressive LV dysfunction.
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